High-Dose Chemotherapy and ASCT for Older and Fit Patients With Primary Diffuse Large B-Cell CNS Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial
Lancet Haematol 2024 Jan 29;[EPub Ahead of Print], E Schorb, LK Isbell, A Kerkhoff, S Mathas, F Braulke, G Egerer, A Röth, S Schliffke, P Borchmann, U Brunnberg, F Kroschinsky, R Möhle, A Rank, D Wellnitz, B Kasenda, L Pospiech, J Wendler, F Scherer, M Deckert, E Henkes, P von Gottberg, D Gmehlin, M Backenstraß, A Jensch, E Burger-Martin, O Grishina, H Fricker, N Malenica, A Orbán, J Duyster, G Ihorst, J Finke, G IllerhausFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.